Type to search

COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials | Pharmtech Focus
Zocdoc raises $150 million | Pharmtech Focus
FDA approves new treatment for adults with relapsed or refractory large-b-cell lymphoma | Pharmtech Focus